Charles Russell Speechlys’ Capital Markets team are equal sixth in AIM Adviser Rankings Guide for total number of AIM clients
The Capital Markets team at Charles Russell Speechlys are pleased to see an increase in a number of areas within the AIM Adviser Rankings guide, most notably listed as equal sixth in the total number of AIM clients. AIM Adviser Rankings Guide ranks all advisers by their total number of AIM, FTSE AIM 100 and FTSE AIM UK 50 clients, as well as the eight main industry sectors. In line with our sector focus, our total increases was supported by an increase in Consumer Services and Financials, as well as a consistent ranking in Healthcare and Technology.
Recent work highlights include acting for foreign exchange specialist Alpha FX on their IPO on AIM, which raised £30 million and the joint bookrunners and corporate brokers on the placing and subscription in March by Duke Royalty, a diversified royalty investing company, which raised £15 million on the company's re-admission to AIM. Further information about our work in the Main Market can be found here.
Andrew Collins, Partner and head of the Capital Markets team commented: "We are committed to supporting entrepreneurial and growth businesses and regularly support them on exits via the AIM market. Recent reports show that the London Stock Exchange markets are outstripping their European rivals, providing our clients with a viable option for securing long term future growth".
For more information, please contact Andrew Collins on +44 (0)20 7427 6511 or firstname.lastname@example.org.
News & Insights
Charles Russell Speechlys advises Kreos Capital VI (UK) Ltd on growth capital investment in retail monitoring solution BeMyEye
Charles Russell Speechlys has advised Kreos Capital VI (UK) Limited on its €3 million growth capital investment in BeMyEye Holdings Limited.
The Tech Entrepreneur’s Journey – The Capital Requirements
Look into the most common methods we see used to raise working capital for the proposed new business during its corporate life cycle.